Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 02:17 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Sleep Apnea: Mechanism and Cerebrovascular Consequences
NCT00108602 · US Department of Veterans Affairs · NA · withdrawn · last registry update 2015-06-26 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “This study of the overall grant was not pursued as the aims were changed” | – | Registry record, US Department of Veterans Affairs |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CA1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2016-04-28Phase 3 first posted: University of Zurich, Acetazolamide + Placebo (NCT02755298)
- 2016-04-28Phase 3 first posted: University of Zurich, Acetazolamide + Placebo (NCT02755259)
- 2016-03-14Results posted on the registry: VA Office of Research and Development, Acetazolamide + Buspirone (NCT00746954)
- 2016-03-14Also stopped (terminated): VA Office of Research and Development, Acetazolamide + Buspirone (NCT00746954)
- 2015-12-30Phase 3 first posted: Tanta University, Methocarbamol + Calcium Carbonate (NCT02642874)
- 2015-12-15Results posted on the registry: University of Florida, Diphenhydramine + Pantoprazole (NCT02142712)
- 2015-11-13Phase 3 first posted: Stanford University, Budesonide + Acetazolamide (NCT02604173)
- 2015-09-24Also stopped (withdrawn): University of Florida, Acetazolamide + Nimodipine (NCT02165644)
- 2015-06-04Results posted on the registry: Rabin Medical Center, Furosemide first, then Acetazolamide + Acetazolamide first, then Furosemide (NCT01146288)
- 2015-04-27Also stopped (withdrawn): Merck Sharp & Dohme LLC, MK-0663B + DOLOCAM PLUS® (NCT01979510)
- 2015-03-17Phase 3 first posted: University of Miami, Latanoprost + Bimatoprost (NCT02390284)
- 2014-10-24Results posted on the registry: Colorado State University, Placebo + Aminophylline (NCT01702025)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision